Your browser doesn't support javascript.
loading
Open drug discovery in Alzheimer's disease.
Axtman, Alison D; Brennan, Paul E; Frappier-Brinton, Tristan; Betarbet, Ranjita; Carter, Gregory W; Fu, Haian; Gileadi, Opher; Greenwood, Anna K; Leal, Karina; Longo, Frank M; Mangravite, Lara M; Edwards, Aled M; Levey, Allan I.
Affiliation
  • Axtman AD; University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.
  • Brennan PE; Oxford Drug Discovery Institute University of Oxford Oxford UK.
  • Frappier-Brinton T; Structural Genomics Consortium University of Toronto Toronto Ontario Canada.
  • Betarbet R; Emory University School of Medicine Atlanta Georgia USA.
  • Carter GW; The Jackson Laboratory Bar Harbor Maine USA.
  • Fu H; Emory University School of Medicine Atlanta Georgia USA.
  • Gileadi O; Structural Genomics Consortium Karolinska Institute Stockholm Sweden.
  • Greenwood AK; Sage Bionetworks Seattle Washington USA.
  • Leal K; Sage Bionetworks Seattle Washington USA.
  • Longo FM; Stanford University School of Medicine Stanford California USA.
  • Mangravite LM; Sage Bionetworks Seattle Washington USA.
  • Edwards AM; Structural Genomics Consortium University of Toronto Toronto Ontario Canada.
  • Levey AI; Emory University School of Medicine Atlanta Georgia USA.
Alzheimers Dement (N Y) ; 9(2): e12394, 2023.
Article in En | MEDLINE | ID: mdl-37215505
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Alzheimers Dement (N Y) Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Alzheimers Dement (N Y) Year: 2023 Document type: Article